Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 78
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01284530 | Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy | ||
| NCT03924492 | Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression | ||
| NCT03247556 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD | ||
| NCT02942004 | A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B) | ||
| NCT05518578 | Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy | ||
| NCT00626236 | Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems | ||
| NCT00918047 | Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients | ||
| NCT05102552 | Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healthy Adult Subjects | ||
| NCT04016792 | Classroom Study of SPN-812 in Children With ADHD | ||
| NCT01085461 | Assessment of Suicidality in Epilepsy - Rating Tools | ||
| NCT02614547 | A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression | ||
| NCT04781140 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD | ||
| NCT05152680 | Mass Balance Study of NV-5138 in Healthy Male Subjects. | ||
| NCT02052739 | Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus | ||
| NCT04099667 | Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity | ||
| NCT05619692 | A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) | ||
| NCT05066672 | Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression | ||
| NCT01107496 | Evaluation of Immediate-Release Viloxazine in Adults With ADHD | ||
| NCT00908349 | Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy | ||
| NCT06185985 | Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms | ||
| NCT03615703 | Functional MRI Study in Healthy Children Engaged in Aggressive Behaviors | ||
| NCT04050293 | Therapy for Migraine Prevention in Children 6-11 Years of Age | ||
| NCT02433314 | An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus | ||
| NCT03247517 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD | ||
| NCT06235905 | Open-Label of SPN-820 in Adults With Major Depressive Disorder | ||
| NCT02736656 | Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) | ||
| NCT04815967 | Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity | ||
| NCT05318937 | A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment | ||
| NCT06798896 | RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset Seizures | ||
| NCT03771586 | A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects | ||
| NCT03156439 | Bioavailability, Safety, and Tolerability of BIS-001 ER | ||
| NCT06259331 | Evaluation of Viloxazine and Its Metabolite 5-Hydroxy-viloxazine Glucuronide Into Breast Milk in Healthy Lactating Women | ||
| NCT03787758 | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B | ||
| NCT04016779 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD | ||
| NCT02618434 | Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2) | ||
| NCT02285504 | Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression | ||
| NCT02477618 | A Study With SAGE-547 for Super-Refractory Status Epilepticus | ||
| NCT00918424 | Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects | ||
| NCT05049343 | Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants | ||
| NCT02618408 | Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1) | ||
| NCT01994109 | Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects | ||
| NCT02633527 | Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD | ||
| NCT04602624 | A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) | ||
| NCT00772603 | Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures | ||
| NCT03247530 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD | ||
| NCT03665038 | A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD) | ||
| NCT05059600 | A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting | ||
| NCT05655520 | A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease | ||
| NCT01246765 | National Pregnancy Registry for Psychiatric Medications | ||
| NCT02339064 | Infusion of Apomorphine: Long-term Safety Study |
